-
Summary
As the biopharma industry advances, understanding the commercial potential and competitive dynamics of Alzheimer’s drug development is more critical than ever. Join our speakers for an exclusive session on this rapidly evolving landscape.
In this webinar, we will explore how investors and corporate strategy teams can leverage AI-powered research tools and forward-looking consensus estimates to assess emerging Alzheimer’s therapies. We will examine key players, pipeline progress, and market forecasts to uncover actionable insights using S&P Capital IQ Pro and Visible Alpha.
Apply the learning, so you can:
- Understand how funding flows and investor priorities are evolving.
- Track leading therapies, emerging entrants, and key clinical milestones.
- Evaluate the total addressable market using product-level estimates.
- Identify signals of success in Phase I/II trials to assess the long-term viability of new therapies.
- Monitor trends and support strategic decisions using AI-powered tools on S&P Capital IQ Pro.
Speakers
S&P Global Market Intelligence
Derek Walker
Business Development Lead, North America Corporate & Industrial Sectors
Derek joined S&P Global in 2021 supporting our Corporates Clients. His experience spans Customer Success and Business Development for Data & Research.
S&P Global Market Intelligence
Hamish Wells
Commercial Team Lead, Visible Alpha
Hamish is a Representative in the Visible Alpha desktop and feed distribution team at S&P Market Intelligence with a specialisation in biopharma market data aimed Corporates and Buyside professionals. He joined S&P Global as part of the strategic acquisition of Visible Alpha in May 2024. During his time distributing Visible Alpha's quantitative broker forecast dataset, Hamish has worked with a broad range of clients including Corporate Investor Relations, Private Equity, Professional Services, and Hedge Funds professionals before specialising in working with Healthcare professionals and Analysts. Before Visible Alpha, Hamish worked as an Equity Research Analyst covering US Tech. Hamish received a BSc in Economics from the University of Manchester in 2018.
Questions?
Please contact us if you need more information or have trouble accessing the webinar.